4-Amino-1-((2R,3R,4R,5R)-4-hydroxy-5-(hydroxymethyl)-3-(2-methoxyethoxy)tetrahydrofuran-2-yl)-5-methylpyrimidin-2(1H)-one, 95+%, 1g

(S)-3-Amino-3-(4-hydroxyphenyl)propanoic acid, 95.0%, 250mg

Osmio ICP soluzione standard, ROTI®Star, 100 ml, confezione in vetro

2,6-Dichloroquinazolin-4(3H)-one, 95.0%, 1g

tert-Butyl 7-oxo-6,7-dihydrothieno[3,2-c]pyridine-5(4H)-carboxylate, 97%, 500mg

5,5'-(1,4-Phenylenebis(oxy))bis(isobenzofuran-1,3-dione), 97%, 5g

4-(chlorosulfonyl)-2-fluorobenzoic acid, 97.0%, 10g

4-Acridinecarboxamide, N-[4-[2-(3,4-dihydro-6,7-dimethoxy-2(1H)-isoquinolinyl)ethyl]phenyl]-9,10-dihydro-5-methoxy-9-oxo-, hydrochloride (1:1), 98%, 25mg

4-Bromo-2-methyl-5-nitroaniline, 95.0%, 5g

Cyclohexene>99.0%(GC)25mL

2-Amino-1-(3-methylphenyl)ethan-1-one hydrochloride, 98%, 1g

(2-Bromo-4-fluorophenyl)hydrazine, 95.0%, 1g

Diethyl Maleate>90.0%(GC)500mL